Start with its own history
At 37.46×, TECH is 45.1% below its 10-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
NASDAQ · TECHBiotechnologyUpdated Nov 2, 2026
Bio-Techne Corporation P/E ratio
Current valuation, historical context, and peer comparisons.
Current P/E ratio
37.46×
45.1% belowthe 10-year annual average
Share price72.68
÷Earnings per share1.94
Price and EPS in quote currency. Calculation details
Investors are paying 37.46 for every 1 of reported earnings per share.
P/E over time
2017 – 2026
Annual P/ESelected-period average 68.20×
3-year average78.93×3 positive annual observations
5-year average66.39×5 positive annual observations
10-year average68.20×10 positive annual observations
Peer median · TTM36.72×6 peers with positive P/E
Historical P/E ratios
Annual period-end data · 25 observations
| Period end | P/E | Change |
|---|---|---|
| Jun 30, 2026 | 60.38× | -44.8% |
| Jun 30, 2025 | 109.47× | +63.6% |
| Jun 30, 2024 | 66.93× | +48.4% |
| Jun 30, 2023 | 45.10× | -10.0% |
| Jun 30, 2022 | 50.09× | -59.5% |
| Jun 30, 2021 | 123.70× | +181.1% |
| Jun 30, 2020 | 44.01× | -46.2% |
| Jun 30, 2019 | 81.75× | +85.6% |
View all 25 annual observations +
| Period end | P/E | Change |
|---|---|---|
| Jun 30, 2018 | 44.04× | -22.1% |
| Jun 30, 2017 | 56.50× | +40.3% |
| Jun 30, 2016 | 40.27× | +19.4% |
| Jun 30, 2015 | 33.73× | +9.3% |
| Jun 30, 2014 | 30.85× | +34.6% |
| Jun 30, 2013 | 22.92× | -6.1% |
| Jun 30, 2012 | 24.41× | -11.0% |
| Jun 30, 2011 | 27.42× | +41.3% |
| Jun 30, 2010 | 19.41× | -14.8% |
| Jun 30, 2009 | 22.79× | -22.3% |
| Jun 30, 2008 | 29.32× | +10.7% |
| Jun 30, 2007 | 26.48× | -2.2% |
| Jun 30, 2006 | 27.09× | -3.3% |
| Jun 30, 2005 | 28.00× | -17.5% |
| Jun 30, 2004 | 33.94× | +20.7% |
| Jun 30, 2003 | 28.11× | -35.4% |
| Jun 30, 2002 | 43.50× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
How TECH compares
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
 TECH This stockBio-Techne Corporation | 37.46× |
 BIOBio-Rad Laboratories, Inc. | 44.67× |
 QGENQiagen N.V. | 25.84× |
 RVTYRevvity, Inc. | 72.71× |
 DHRDanaher Corporation | 37.42× |
 AAgilent Technologies, Inc. | 33.95× |
 TMOThermo Fisher Scientific Inc. | 36.02× |
 BRKRBruker Corporation | N/M |
 TXG10x Genomics, Inc. | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
What does TECH’s P/E tell you?
Compare like with like
The median of the 6 positive peer ratios above is 36.72×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
Check what drives earnings
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Take TECH into your spreadsheet
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore WisesheetsQuarterly P/E · latest quarterLQ selects the latest reported quarter. Requires the Wisesheets add-in. See available data
=WISE("TECH", "PE Ratio", "LQ")Sources & calculation methodology
Current P/E
Share price 72.68 ÷ EPS 1.94 = 37.46×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 2, 2026; this is not a real-time trading quote.
History & averages
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
Data definitions and limitations
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
TECH P/E ratio: common questions
The essentials behind the numbers.
Bio-Techne Corporation's current P/E is 37.46× based on the quote data last updated Nov 2, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.